vers la météo de la validation par utilisateur
+------------OBJ:V-N------------+ +MOD_ATT:N-+-----SUBJ:V_PASS-N----+ | +-MOD_ATT:N-ADJ+--------APPOS-------+ | +MOD_AT+COMP:N-N(i+ +COMP:V_PASS-N(w+ | +MOD_ATT+ +MOD_ATT+ | | | | | | | | | | | | Cutaneous T cell lymphoma in humans is associated with frameshift mutant __SP__ __NODE__ ( 3 ' mRNA truncation ) . MOD_ATT:N-N (lymphoma,T) MOD_ATT:N-N (lymphoma,cell) COMP:N-N(in) (lymphoma,human) SUBJ:V_PASS-N (associate,lymphoma) COMP:V_PASS-N(with) (associate,frameshift) OBJ:V-N (with,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,truncation) MOD_ATT:N-N (truncation,mRNA)
+----------COMP:V_PASS-N(with)----------+ | +------MOD_ATT:N-N------+ +MOD_ATT:N-+-----SUBJ:V_PASS-N----+ | +-MOD_ATT:N-ADJ+--------APPOS-------+ | +MOD_AT+COMP:N-N(i+ | | | +MOD_ATT+ +MOD_ATT+ | | | | | | | | | | | Cutaneous T cell lymphoma in humans is associated with frameshift mutant __SP__ __NODE__ ( 3 ' mRNA truncation ) . MOD_ATT:N-N (lymphoma,T) MOD_ATT:N-N (lymphoma,cell) COMP:N-N(in) (lymphoma,human) SUBJ:V_PASS-N (associate,lymphoma) COMP:V_PASS-N(with) (associate,__NODE__) MOD_ATT:N-N (__NODE__,frameshift) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,truncation) MOD_ATT:N-N (truncation,mRNA)
+---MOD_ATT:N-N--+ +------------OBJ:V-N------------+ | +MOD_ATT:N-+-----SUBJ:V_PASS-N----+ | +-MOD_ATT:N-ADJ+--------APPOS-------+ | | +MOD_AT+COMP:N-N(i+ +COMP:V_PASS-N(w+ | +MOD_ATT+ +MOD_ATT+ | | | | | | | | | | | | | Cutaneous T cell lymphoma in humans is associated with frameshift mutant __SP__ __NODE__ ( 3 ' mRNA truncation ) . MOD_ATT:N-N (lymphoma,cutaneous) MOD_ATT:N-N (lymphoma,T) MOD_ATT:N-N (lymphoma,cell) COMP:N-N(in) (lymphoma,human) SUBJ:V_PASS-N (associate,lymphoma) COMP:V_PASS-N(with) (associate,frameshift) OBJ:V-N (with,__NODE__) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,truncation) MOD_ATT:N-N (truncation,mRNA)
+----------COMP:V_PASS-N(with)----------+ +---MOD_ATT:N-N--+ | +------MOD_ATT:N-N------+ | +MOD_ATT:N-+-----SUBJ:V_PASS-N----+ | +-MOD_ATT:N-ADJ+--------APPOS-------+ | | +MOD_AT+COMP:N-N(i+ | | | +MOD_ATT+ +MOD_ATT+ | | | | | | | | | | | | Cutaneous T cell lymphoma in humans is associated with frameshift mutant __SP__ __NODE__ ( 3 ' mRNA truncation ) . MOD_ATT:N-N (lymphoma,cutaneous) MOD_ATT:N-N (lymphoma,T) MOD_ATT:N-N (lymphoma,cell) COMP:N-N(in) (lymphoma,human) SUBJ:V_PASS-N (associate,lymphoma) COMP:V_PASS-N(with) (associate,__NODE__) MOD_ATT:N-N (__NODE__,frameshift) MOD_ATT:N-ADJ (__NODE__,mutant) MOD_ATT:N-ADJ (__NODE__,__SP__) APPOS (__NODE__,truncation) MOD_ATT:N-N (truncation,mRNA)
+------COMP:V_PASS-N(with)------+ | +------------OBJ:V-N------------+ +MOD_ATT:N-+-----SUBJ:V_PASS-N----+ | +--MOD_ATT:N-N--+ +--------APPOS-------+ | +MOD_AT+COMP:N-N(i+ | | | +MOD_AT+ | +MOD_ATT+ | | | | | | | | | | | | Cutaneous T cell lymphoma in humans is associated with frameshift mutant __SP__ __NODE__ ( 3 ' mRNA truncation ) . MOD_ATT:N-N (lymphoma,T) MOD_ATT:N-N (lymphoma,cell) COMP:N-N(in) (lymphoma,human) SUBJ:V_PASS-N (associate,lymphoma) COMP:V_PASS-N(with) (associate,__SP__) OBJ:V-N (with,__NODE__) MOD_ATT:N-N (__SP__,frameshift) MOD_ATT:N-ADJ (__SP__,mutant) APPOS (__NODE__,truncation) MOD_ATT:N-N (truncation,mRNA)
+------COMP:V_PASS-N(with)------+ +---MOD_ATT:N-N--+ | +------------OBJ:V-N------------+ | +MOD_ATT:N-+-----SUBJ:V_PASS-N----+ | +--MOD_ATT:N-N--+ +--------APPOS-------+ | | +MOD_AT+COMP:N-N(i+ | | | +MOD_AT+ | +MOD_ATT+ | | | | | | | | | | | | | Cutaneous T cell lymphoma in humans is associated with frameshift mutant __SP__ __NODE__ ( 3 ' mRNA truncation ) . MOD_ATT:N-N (lymphoma,cutaneous) MOD_ATT:N-N (lymphoma,T) MOD_ATT:N-N (lymphoma,cell) COMP:N-N(in) (lymphoma,human) SUBJ:V_PASS-N (associate,lymphoma) COMP:V_PASS-N(with) (associate,__SP__) OBJ:V-N (with,__NODE__) MOD_ATT:N-N (__SP__,frameshift) MOD_ATT:N-ADJ (__SP__,mutant) APPOS (__NODE__,truncation) MOD_ATT:N-N (truncation,mRNA)